Sabrina Yang

Sabrina Yang's work experience can be summarized as follows:

1. Empress Therapeutics (2018 - present):

- Co-Founder & Chief Innovation Officer (July 2022 - present)

- Co-Founder (June 2018 - present)

2. Flagship Pioneering (2017 - present):

- Principal (November 2021 - present)

- Senior Associate (November 2019 - October 2021)

- Associate (December 2017 - October 2019)

- Responsibilities include creating and developing disruptive life science ventures, evaluating and funding early-stage biotech ideas, teams, and companies.

3. Flagship Labs 91 (2021 - 2023):

- Co-Founder

4. Massachusetts Institute of Technology (2016 - 2017):

- Postdoctoral Translational Fellow

- Involved in the development of a small molecule drug delivery platform for cancer immunotherapy.

- Project leader in the Biomed Entrepreneurship Course at the Broad Institute.

- Speaker at 2017 Immunotherapy of Cancer Conference (ITOC4) in Prague.

- Participant in Harvard Healthcare Innovation and Commercialization course.

5. Flagship Pioneering (2017):

- Venture Creation Fellow

- Originated platform technology ideas and pitched them to Flagship partners and CEO.

6. Massachusetts Institute of Technology (2011 - 2016):

- Graduate Researcher in the Laboratory of Dr. Darrell Irvine

- Developed a strategy to enhance intracellular small molecule drug targeting to CD8+ T cells in vivo.

- Filed two patents.

7. EPFL (École polytechnique fédérale de Lausanne) (2014):

- Visiting Scholar

8. National Cheng Kung University (2009):

- Researcher

9. UCLA (2006):

- Summer Student.

Sabrina Yang completed their Bachelor of Science (BS) degree in Materials Science and Engineering at National Tsing Hua University. Sabrina then pursued their Master of Science degree in Materials Science and Engineering at the Massachusetts Institute of Technology (MIT). Following that, they went on to earn their Doctor of Philosophy (Ph.D.) in Materials Science and Engineering, also from MIT.